Concepedia

Ara A. Vaporciyan

AA

Statistics

Publications

253

Citations

18.7K

H-Index

79

Active since

1993

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Thoracic Surgery Foundation

Ara A. Vaporciyan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and surgery.

ORCID

Publications per year

1993–2025

253

Publications

253

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt et al. · Nature Medicine · 2021 · 604 citations · Full text

, , +17

C5a-induced expression of P-selectin in endothelial cells.

Kimberly E. Foreman, Ara A. Vaporciyan, Brian K. Bonish et al. · Journal of Clinical Investigation · 1994 · 474 citations · Full text

, , +16

Involvement of Platelet-Endothelial Cell Adhesion Molecule-1 in Neutrophil Recruitment in Vivo

Ara A. Vaporciyan, Horace M. DeLisser, Horng-Chin Yan et al. · Science · 1993 · 459 citations

, , +17

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy

Apar Pataer, Neda Kalhor, Arlene M. Correa et al. · Journal of Thoracic Oncology · 2012 · 365 citations · Full text

, , +16

Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial

Charles S. Cleeland, Xin Shelley Wang, Qiuling Shi et al. · Journal of Clinical Oncology · 2011 · 351 citations · Full text

, , +17

1–5 of 253